169
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

SMILES-Based QSAR and Molecular Docking Study of Oseltamivir Derivatives as Influenza Inhibitors

, ORCID Icon, , &
Pages 3257-3277 | Received 22 Sep 2021, Accepted 08 Apr 2022, Published online: 23 Apr 2022

References

  • Anis Khan, Mohammed A. AlBalwi, Ibraheem AlAbdulkareem, Abdulrahman AlMasoud, Abdulrahman AlAsiri, Wardah AlHarbi, Faisal AlSehile, Aiman El-Saed, and Hanan H. Balkhy, “Atypical Influenza A(H1N1)pdm09 Strains Caused an Influenza Virus Outbreak in Saudi Arabia during the 2009–2011 Pandemic Season,” Journal of Infection and Public Health 12, no. 4 (2019): 557–67. doi:10.1016/j.jiph.2019.01.067.
  • G. Neumann, T. Noda, and Y. Kawaoka, “Emergence and Pandemic Potential of Swine-Origin H1N1 Influenza Virus,” Nature 459, no. 7249 (2009): 931–9. doi:10.1038/nature08157.
  • E. D. Kilbourne, “Inhibition of Influenza Virus Multiplication with a Glucose Antimetabolite (2-deoxy-D-Glucose),” Nature 183, no. 4656 (1959): 271–2. doi:10.1038/183271b0.
  • Irma Lopez-Martinez, Amanda Balish, Gisela Barrera-Badillo, Joyce Jones, Tatiana E. Nuñez-García, Yunho Jang, Rodrigo Aparicio-Antonio, Eduardo Azziz-Baumgartner, Jessica A. Belser, José E. Ramirez-Gonzalez, et al, “Highly Pathogenic Avian Influenza A (H7N3) Virus in Poultry Workers, Mexico, 2012,” Emerging Infectious Diseases 19, no. 9 (2013): 1531., doi:10.3201/eid1909.130087.
  • J. K. Taubenberger, and D. M. Morens, “1918 Influenza: The Mother of All Pandemics,” Revista Biomedica 17, no. 1 (2006): 69–79.
  • A. Moscona, “Oseltamivir Resistance-Disabling Our Influenza Defenses,” The New England Journal of Medicine 353, no. 25 (2005): 2633–6. doi:10.1056/NEJMp058291.
  • Ahsan Chaudhry, Nathalie Bastien, Yan Li, Allison Scott, Kanti Pabbaraju, Douglas Stewart, Sallene Wong, and Steven J. Drews, “Oseltamivir Resistance in an Influenza A (H3N2) Virus Isolated from an Immunocompromised Patient during the 2014-2015 influenza season in Alberta, Canada,” Influenza and Other Respiratory Viruses 10, no. 6 (2016): 532–5. doi:10.1111/irv.12415.
  • S. Ahmadi, M. R. Khazaei, and A. Abdolmaleki, “Quantitative Structure–Property Relationship Study on the Intercalation of Anticancer Drugs with ct-DNA,” Medicinal Chemistry Research 23, no. 3 (2014): 1148–61. doi:10.1007/s00044-013-0716-z.
  • Shahin Ahmadi, Fariba Mardinia, Neda Azimi, Mahnaz Qomi, and Ebrahim Balali, “Prediction of Chalcone Derivative Cytotoxicity Activity against MCF-7 Human Breast Cancer Cell by Monte Carlo Method,” Journal of Molecular Structure 1181 (2019): 305–11. doi:10.1016/j.molstruc.2018.12.089.
  • Shahin Ahmadi, Hosein Ghanbari, Shahram Lotfi, and Neda Azimi, “Predictive QSAR Modeling for the Antioxidant Activity of Natural Compounds Derivatives Based on Monte Carlo Method,” Molecular Diversity 25, no. 1 (2021): 87–11. doi:10.1007/s11030-019-10026-9.
  • A. A. Toropov, and A. P. Toropova, “The Unreliability of the Reliability Criteria in the Estimation of QSAR for Skin Sensitivity: A Pun or a Reliable Law?,” Toxicology Letters 340 (2021): 133–40.
  • A. G. Mercader, and A. B. Pomilio, “QSAR Study of Flavonoids and Biflavonoids as Influenza H1N1 Virus Neuraminidase Inhibitors,” European Journal of Medicinal Chemistry 45, no. 5 (2010): 1724–30. doi:10.1016/j.ejmech.2010.01.005.
  • Yong Cong, Bing-ke Li, Xue-gang Yang, Ying Xue, Yu-zong Chen, and Yi Zeng, “Quantitative Structure–Activity Relationship Study of Influenza Virus Neuraminidase a/PR/8/34 (H1N1) Inhibitors by Genetic Algorithm Feature Selection and Support Vector Regression,” Chemometrics and Intelligent Laboratory Systems 127 (2013): 35–42. doi:10.1016/j.chemolab.2013.05.012.
  • Marzieh Yaeghoobi, Neni Frimayanti, Chin Fei Chee, Kusaira K. Ikram, Belal O. Najjar, Sharifuddin M. Zain, Zanariah Abdullah, Habibah A. Wahab, and Noorsaadah Abd Rahman, “QSAR, in Silico Docking and in Vitro Evaluation of Chalcone Derivatives as Potential Inhibitors for H1N1 Virus Neuraminidase,” Medicinal Chemistry Research 25, no. 10 (2016): 2133–42. doi:10.1007/s00044-016-1636-5.
  • Yanni Lai, Yiwen Yan, Shanghui Liao, Yun Li, Yi Ye, Ni Liu, Fang Zhao, and Peiping Xu, “ 3D-Quantitative Structure-Activity Relationship and Antiviral Effects of Curcumin Derivatives as Potent Inhibitors of Influenza H1N1 Neuraminidase,” Archives of Pharmacal Research 43, no. 5 (2020): 489–502. doi:10.1007/s12272-020-01230-5.
  • Bei-Tao Hong, Chun-Lin Chen, Jim-Min Fang, Keng-Chang Tsai, Shi-Yun Wang, Wen-I. Huang, Yih-Shyun E. Cheng, and Chi-Huey Wong, “Oseltamivir Hydroxamate and Acyl Sulfonamide Derivatives as Influenza Neuraminidase inhibitors,” Bioorganic & Medicinal Chemistry 22, no. 23 (2014): 6647–54. doi:10.1016/j.bmc.2014.10.005.
  • Zhaoliang Li, Yanchun Meng, Shengtao Xu, Wang Shen, Zhaoqing Meng, Zhenzhong Wang, Gang Ding, Wenzhe Huang, Wei Xiao, Jinyi Xu, et al, “Discovery of Acylguanidine Oseltamivir Carboxylate Derivatives as Potent Neuraminidase Inhibitors,” Bioorganic & Medicinal Chemistry 25, no. 10 (2017): 2772–81., doi:10.1016/j.bmc.2017.03.052.
  • Bei-Tao Hong, Yih-Shyun E. Cheng, Ting-Jen Cheng, and Jim-Min Fang, “Boronate, Trifluoroborate, Sulfone, Sulfinate and Sulfonate Congeners of Oseltamivir Carboxylic Acid: Synthesis and Anti-Influenza Activity,” European Journal of Medicinal Chemistry 163 (2019): 710–21. doi:10.1016/j.ejmech.2018.12.027.
  • Peng-Hao Hsu, Din-Chi Chiu, Kuan-Lin Wu, Pei-Shan Lee, Jia-Tsrong Jan, Yih-Shyun E. Cheng, Keng-Chang Tsai, Ting-Jen Cheng, and Jim-Min Fang, “Acylguanidine Derivatives of Zanamivir and Oseltamivir: Potential Orally Available Prodrugs against Influenza Viruses,” European Journal of Medicinal Chemistry 154 (2018): 314–23. doi:10.1016/j.ejmech.2018.05.030.
  • Jian Zhang, Vasanthanathan Poongavanam, Dongwei Kang, Chiara Bertagnin, Huamei Lu, Xiujie Kong, Han Ju, Xueyi Lu, Ping Gao, Ye Tian, et al, “Optimization of N-Substituted Oseltamivir Derivatives as Potent Inhibitors of Group-1 and -2 Influenza A Neuraminidases, Including a Drug-Resistant Variant ,” Journal of Medicinal Chemistry 61, no. 14 (2018): 6379–97., doi:10.1021/acs.jmedchem.8b00929.
  • S. Ahmadi, “Mathematical Modeling of Cytotoxicity of Metal Oxide Nanoparticles Using the Index of Ideality Correlation Criteria,” Chemosphere 242 (2020): 125192.
  • S. Ahmadi, and A. Akbari, “Prediction of the Adsorption Coefficients of Some Aromatic Compounds on Multi-Wall Carbon Nanotubes by the Monte Carlo Method,” SAR and QSAR in Environmental Research 29, no. 11 (2018): 895–909. doi:10.1080/1062936X.2018.1526821.
  • A. A. Toropov, and A. P. Toropova, “Quasi-SMILES as a Basis for the Development of Models for the Toxicity of ZnO Nanoparticles,” Science of the Total Environment 772 (2021) : 145532. doi:10.1016/j.scitotenv.2021.145532.
  • Alla P. Toropova, Andrey A. Toropov, Danuta Leszczynska, and Jerzy Leszczynski, “How the CORAL Software Can Be Used to Select Compounds for Efficient Treatment of Neurodegenerative Diseases?,” Toxicology and Applied Pharmacology 408 (2020): 115276.
  • Josivan da Silva Costa, Karina da Silva Lopes Costa, Josiane Viana Cruz, Ryan da Silva Ramos, Luciane Barros Silva, Davi Do Socorro Barros Brasil, Carlos Henrique Tomich de Paula da Silva, Cleydson Breno Rodrigues Dos Santos, and Williams Jorge da Cruz Macedo, “Virtual Screening and Statistical Analysis in the Design of New Caffeine Analogues Molecules with Potential Epithelial Anticancer Activity,” Current Pharmaceutical Design 24, no. 5 (2018): 576–94. doi:10.2174/1381612823666170711112510.
  • S. Ahmadi, and E. Habibpour, “Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents,” Anti-Cancer Agents in Medicinal Chemistry 17, no. 4 (2017): 552–65. doi:10.2174/1871520616666160811162105.
  • S. Ahmadi, S. Lotfi, and P. Kumar, “A Monte Carlo Method Based QSPR Model for Prediction of Reaction Rate Constants of Hydrated Electrons with Organic Contaminants,” SAR and QSAR in Environmental Research 31, no. 12 (2020): 935–50. doi:10.1080/1062936X.2020.1842495.
  • P. Kumar, A. Kumar, and J. Sindhu, “Design and Development of Novel Focal Adhesion Kinase (FAK) Inhibitors Using Monte Carlo Method with Index of Ideality of Correlation to Validate QSAR,” SAR and QSAR in Environmental Research 30, no. 2 (2019): 63–80. doi:10.1080/1062936X.2018.1564067.
  • Manisha, S. Chauhan, P. Kumar, and A. Kumar, “Development of Prediction Model for Fructose-1, 6-Bisphosphatase Inhibitors Using the Monte Carlo Method,” SAR and QSAR in Environmental Research 30, no. 3 (2019): 145–59. doi:10.1080/1062936X.2019.1568299.
  • S. Lotfi, S. Ahmadi, and P. Zohrabi, “QSAR Modeling of Toxicities of Ionic Liquids toward Staphylococcus aureus Using SMILES and Graph Invariants,” Structural Chemistry 31, no. 6 (2020): 2257–70. doi:10.1007/s11224-020-01568-y.
  • Shahin Ahmadi, Elahe Babaee, and Mohammad Reza Khazaei, “Application of Self Organizing Maps and GA-MLR for the Estimation of Stability Constant of 18-Crown-6 Ether Derivatives with Sodium Cation,” Journal of Inclusion Phenomena and Macrocyclic Chemistry 79, no. 1-2 (2014): 141–9. doi:10.1007/s10847-013-0337-7.
  • Andrey A. Toropov, Alla P. Toropova, Aleksandar M. Veselinović, Danuta Leszczynska, and Jerzy Leszczynski, “SARS-CoV Mpro Inhibitory Activity of Aromatic Disulfide Compounds: QSAR Model,” Journal of Biomolecular Structure & Dynamics 40, no. 2 (2022): 780–7. doi:10.1080/07391102.2020.1818627.
  • S. Ahmadi, and S. Ganji, “Genetic Algorithm and Self-Organizing Maps for QSPR Study of Some N-Aryl Derivatives as Butyrylcholinesterase Inhibitors,” Current Drug Discovery Technologies 13, no. 4 (2016): 232–53. doi:10.2174/1570163813666160725114241.
  • N. Chirico, and P. Gramatica, “Real External Predictivity of QSAR Models: How to Evaluate It? Comparison of Different Validation Criteria and Proposal of Using the Concordance Correlation Coefficient,” Journal of Chemical Information and Modeling 51, no. 9 (2011): 2320–35. doi:10.1021/ci200211n.
  • P. Kumar, and A. Kumar, “CORAL: QSAR Models of CB1 Cannabinoid Receptor Inhibitors Based on Local and Global SMILES Attributes with the Index of Ideality of Correlation and the Correlation Contradiction Index,” Chemometrics and Intelligent Laboratory Systems 200 (2020) : 103982. doi:10.1016/j.chemolab.2020.103982.
  • P. De, R. B. Aher, and K. Roy, “Chemometric Modeling of Larvicidal Activity of Plant Derived Compounds against Zika Virus Vector Aedes aegypti: Application of ETA Indices,” RSC Advances 8, no. 9 (2018): 4662–70. doi:10.1039/C7RA13159C.
  • M. Javidfar, and S. Ahmadi, “QSAR Modelling of Larvicidal Phytocompounds against Aedes aegypti Using Index of Ideality of Correlation,” SAR and QSAR in Environmental Research 31, no. 10 (2020): 717–39. doi:10.1080/1062936X.2020.1806922.
  • Garrett M. Morris, David S. Goodsell, Robert S. Halliday, Ruth Huey, William E. Hart, Richard K. Belew, and Arthur J. Olson, “Automated Docking Using a Lamarckian Genetic Algorithm and an Empirical Binding Free Energy Function,” Journal of Computational Chemistry 19, no. 14 (1998): 1639–62. doi:10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B.
  • O. Trott, and A. J. Olson, “AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading,” Journal of Computational Chemistry 31, no. 2 (2010): 455–61. doi:10.1002/jcc.21334.
  • Alla P. Toropova, Pablo R. Duchowicz, Laura M. Saavedra, Eduardo A. Castro, and Andrey A. Toropov, “The Use of the Index of Ideality of Correlation to Build up Models for Bioconcentration Factor,” Molecular Informatics 39, no. 7 (2020): 1900070. doi:10.1002/minf.201900070.
  • Yuanchao Xie, Dongqing Xu, Bing Huang, Xiuli Ma, Wenbao Qi, Fangyuan Shi, Xinyong Liu, Yingjie Zhang, and Wenfang Xu, “Discovery of N-Substituted Oseltamivir Derivatives as Potent and Selective Inhibitors of H5N1 Influenza Neuraminidase,” Journal of Medicinal Chemistry 57, no. 20 (2014): 8445–58. doi:10.1021/jm500892k.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.